Why the study?
Moderate to severe postoperative pain affects at least half of patients following cardiac surgery, and inadequate relief can lead to chronic pain and reduced quality of life.
What is the efficacy and safety of various drug groups for postoperative pain relief in cardiac surgery?
What is the efficacy and safety of various drug groups for postoperative pain relief in cardiac surgery?
Multimodal analgesia is an effective and safe priority technique for managing postoperative pain and preventing chronic pain in cardiac surgery patients.
Answers are grounded in this paper and cite their sources.
Supports multimodal analgesia post-cardiac surgery; hypothesis-generating and requires randomized confirmation before practice change.
Intraoperative injury with the formation of a sternotomy wound is inevitably accompanied by postoperative pain, which has a negative effect on the postoperative period and prognosis of patients. Today, moderate and severe pain affects at least half of patients in the early postoperative period after cardiac surgery. Inadequate pain relief in the early postoperative period can lead to chronic pain, which significantly reduces the quality of life of patients. The concept of multimodal analgesia with different painkillers is a priority, effective and safe technique both after cardiac surgery and in other areas of surgery. The current review article is devoted to the analysis of efficacy and safety of various drug groups for postoperative pain relief in cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Сычев et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: